Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Indoco Remedies Limited (INDOCO.BO)

Compare
239.25
-0.70
(-0.29%)
At close: 3:29:00 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Suresh Govind Kare Non-Executive Chairman & Whole time Director 36.89M -- 1939
Mr. Sundeep Vasant Bambolkar Joint MD & Executive Director 75.54M -- 1960
Ms. Aditi Milind Panandikar MD & Executive Director 85.42M -- 1970
Mr. Pramod Ghorpade Chief Financial Officer 17.38M -- --
Mr. Ramanathan Hariharan GM of Legal, Company Secretary & Compliance Officer 5.47M -- --
Dr. Kavita Inamdar Chief Technical Officer -- -- 1967
Mr. Ajay Karajagi President of Sales & Marketing -- -- --
Mr. Rajesh Usgaonker Chief Marketing Officer -- -- --
Mr. Rajan B Saawant Vice President of Corporate HR -- -- --
Mr. Prashant Pathak Head of OSD -- -- --

Indoco Remedies Limited

Indoco House
166 CST Road Santacruz (East)
Mumbai, 400098
India
91 22 6287 1000 https://www.indoco.com
Sector: 
Healthcare
Full Time Employees: 
6,000

Description

Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infectives, vitamins/minerals/nutrients, ophthal/ontological, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, as well as anti-haemorrhoidal creas and calcium preparations. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company also exports its products. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Corporate Governance

Indoco Remedies Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 14, 2025 at 10:59 AM UTC - May 19, 2025 at 12:00 PM UTC

Indoco Remedies Limited Earnings Date

Recent Events

September 19, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers